Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
28 hedge funds and large institutions have $2.32M invested in Acer Therapeutics Inc in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
4% more funds holding
Funds holding: 27 → 28 (+1)
33% less capital invested
Capital invested by funds: $3.49M → $2.32M (-$1.17M)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
85% less call options, than puts
Call options by funds: $2K | Put options by funds: $13K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$243K |
| 2 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$36.3K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$21.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.67M |
| 2 |
MWM
Meridian Wealth Management
Lexington,
Kentucky
|
-$80.6K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$59.1K |
| 4 |
BlackRock
New York
|
-$23.2K |
| 5 |
Two Sigma Investments
New York
|
-$13.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JWA
26
JFS Wealth Advisors
Hermitage,
Pennsylvania
| $23 | – | – | – |
|
|
TIM
27
Thompson Investment Management
Madison,
Wisconsin
| $9 | – | – | – |
|
|
AC
28
Armistice Capital
New York
| – | -$1.67M | -2,204,694 | Closed |
|
|
MWM
29
Meridian Wealth Management
Lexington,
Kentucky
| – | -$80.6K | -106,250 | Closed |
|
|
30
Two Sigma Investments
New York
| – | -$13.7K | -18,091 | Closed |
|
|
WP
31
WealthPLAN Partners
Omaha,
Nebraska
| – | -$759 | -1,000 | Closed |
|
ACER Hedge Fund Activity: Q2 2023 in Review
28 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2023, worth a combined $2.32M — down 33% from $3.49M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ACER positions and 4 closed out — a net gain of 1 holder — while 4 added to existing stakes and 7 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $243K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.67M sold.
- 28 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2023, up from 27 in Q1 2023.
- Funds reported $2.32M of Acer Therapeutics Inc stock for Q2 2023, down 33% quarter-over-quarter.
- 5 funds opened new Acer Therapeutics Inc positions in Q2 2023 and 4 closed out, a net change of +1 holder.
- The largest Acer Therapeutics Inc buyer in Q2 2023 was Hudson Bay Capital Management, an estimated $243K added.
- The largest Acer Therapeutics Inc seller in Q2 2023 was Armistice Capital, an estimated $1.67M sold.
Based on aggregated 13F filings for Q2 2023.